1,447
Views
4
CrossRef citations to date
0
Altmetric
Organic Chemistry

Isolation and identification of berberine and berberrubine metabolites by berberine-utilizing bacterium Rhodococcus sp. strain BD7100Footnote

, , , &
Pages 856-862 | Received 15 Oct 2015, Accepted 13 Dec 2015, Published online: 16 Feb 2016

References

  • Jung HA, Yoon NY, Bae HJ, et al. Inhibitory activities of the alkaloids from Coptidis Rhizoma against aldose reductase. Arch. Pharm. Res. 2008;31:1405–1412.10.1007/s12272-001-2124-z
  • Stermitz FR, Lorenz P, Tawara JN, et al. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. U.S.A. 2000;97:1433–1437.10.1073/pnas.030540597
  • Volleková A, Košťálová D, Sochorová R. Isoquinoline alkaloids from Mahonia aquifolium stem bark are active against Malassezia spp. Folia Microbiol (Praha). 2001;46:107–111.10.1007/BF02873586
  • Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother. Res. 2008;22:999–1012.10.1002/ptr.2399
  • Sack RB, Froehlich JL. Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect. Immun. 1982;35:471–475.
  • Taylor CT, Baird AW. Berberine inhibition of electrogenic ion transport in rat colon. Br. J. Pharmacol. 1995;116:2667–2672.10.1111/bph.1995.116.issue-6
  • Iwasa K, Kamigauchi M, Ueki M, Taniguchi M. Antibacterial activity and structure-activity relationships of berberine analogs. E. J. Med. Chem. 1996;31:469–478.10.1016/0223-5234(96)85167-1
  • Slobodníková L, Kost’álová D,, Labudová D, et al. Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids. Phytother. Res. 2004;18:674–676.10.1002/(ISSN)1099-1573
  • Volleková A, Kost’álová D, Kettmann V, et al. Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids. Phytother. Res. 2003;17:834–837.10.1002/(ISSN)1099-1573
  • Inoue K, Kulsum U, Chowdhury SA, et al. Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines. Anticancer Res. 2005;25:4053–4059.
  • Lin CC, Kao ST, Chen GW, et al. Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. Anticancer Res. 2006;26:227–242.
  • Yu FS, Yang JS, Lin HJ, et al. Berberine inhibits WEHI-3 leukemia cells in vivo. In Vivo. 2007;21:407–412.
  • Kettmann V, Kosfálová D, Jantová S, et al. In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines. Pharmazie. 2004;59:548–551.
  • Kumar A, Ekavali, KC, Mukherjee M, et al. Current knowledge and pharmacological profile of berberine: an update. Eur. J. Pharmacol. 2015;761:288–297.10.1016/j.ejphar.2015.05.068
  • Kim YM, Ha YM, Jin YC, et al. Palmatine from Coptidis rhizoma reduces ischemia-reperfusion-mediated acute myocardial injury in the rat. Food Chem. Toxicol. 2009;47:2097–2102.10.1016/j.fct.2009.05.031
  • Bodiwala HS, Sabde S, Mitra D, et al. Synthesis of 9-substituted derivatives of berberine as anti-HIV agents. Eur. J. Med. Chem. 2011;46:1045–1049.10.1016/j.ejmech.2011.01.016
  • Takeda H, Ishikawa K, Wakana D, et al. 11-hydroxylation of protoberberine in the novel berberine-utilizing aerobic bacterium, Sphingobium sp. Strain BD3100. J. Nat. Prod. 2015;78:2880–2886.
  • Qiu G, Song Y, Zeng P, et al. Combination of upflow anaerobic sludge blanket (UASB) and membrane bioreactor (MBR) for berberine reduction from wastewater and the effects of berberine on bacterial community dynamics. J Hazard. Mater. 2013;246–247:34–43.10.1016/j.jhazmat.2012.12.010
  • Li YH, Li Y, Yang P, et al. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine. Bioorg. Med. Chem. 2010;18:6422–6428.10.1016/j.bmc.2010.06.106
  • Spinozzi S, Colliva C, Camborata C, et al. Berberine and its metabolites: relationship between physicochemical properties and plasma levels after administration to human subjects. J. Nat. Prod. 2014;77:766–772.10.1021/np400607k
  • Liang X, Wang C, Zhang X, et al. United States patent US 20150164870 A1. 2015.
  • Kametani T, Okubo K. Capaurimine and related compounds. 3. Synthesis of dl-5,6,13,13a-tetrahydro-1,2,3,10,11-pentamethoxy-8H-dibenzo[a, g]quinolizine and dl-5,6,13,13a-tetrahydro-2,3,10,11,12-pentamethoxy-8H-dibenzo[a, g]quinolizine (studies on the syntheses of heterocyclic compounds. 286). Yakugaku Zasshi. 1969;89:279–282.
  • Adesomoju AA, Davis WA, Rajaraman R, et al. Total synthesis of leucoxylonine. J. Org. Chem. 1984;49:3220–3222.10.1021/jo00191a037
  • Kranich R, Busemann AS, Bock D, et al. Rational design of novel, potent small molecule pan-selectin antagonists. J Med. Chem. 2007;50:1101–1115.10.1021/jm060536g
  • Berry RC, Eade RA, Simes JJH. Extractives of Australian timbers. XVII. The isolation, structure and synthesis of koparin (7, 2′, 3′-trihydroxy-4′-methoxyisoflavone). Aust. J. Chem. 1977;30:1827–1835.10.1071/CH9771827

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.